TitanFlow formula at a glance
| Label ingredient | Amount | Research context |
|---|---|---|
| Pumpkin Seed Oil | 500 mg | Human BPH/LUTS research exists on pumpkin seed preparations, but that does not prove TitanFlow efficacy. |
| Pygeum Africanum PE 4:1 | 100 mg | Older reviews found modest short-term improvements with some Pygeum preparations. |
| Broccoli PE 4:1 | 50 mg | Plant-compound research exists, but a urinary benefit from this exact dose is not established here. |
| Lycopene 5% | 37.5 mg | Prostate-related clinical evidence is mixed and does not establish treatment of BPH. |
| Beta Sitosterol Complex | 30 mg | Short-term trials of beta-sitosterol preparations reported symptom and flow improvements; long-term evidence is limited. |
Serving size: two capsules. Amounts transcribed from the current label supplied for this build.
Pumpkin seed oil — 500 mg
Pumpkin seed oil is the largest listed ingredient by weight. A randomized clinical trial in men with BPH found symptom-score improvements in both pumpkin seed oil and tamsulosin groups, while the medication group produced larger reductions at some time points. That trial used a different regimen from TitanFlow.
Pygeum africanum PE 4:1 — 100 mg
Pygeum extracts have a long history of research in men with lower urinary tract symptoms. An older systematic review found modest short-term improvements while emphasizing study variability and short duration.
Broccoli sprout extract PE 4:1 — 50 mg
Broccoli sprouts contain glucosinolate-related compounds. The 4:1 ratio describes concentration, not proof of a urinary effect. This site does not claim that 50 mg has been clinically shown to improve urinary symptoms.
Lycopene 5% — 37.5 mg
Lycopene is a carotenoid found in tomatoes. A systematic review of randomized trials concluded that evidence was insufficient to support or refute lycopene for prevention or treatment of BPH or prostate cancer.
Beta Sitosterol Complex — 30 mg
Systematic reviews of short-term beta-sitosterol trials have reported improvements in urinary symptom scores and flow measures, while noting uncertainty about long-term outcomes and differences between preparations.
What ingredient research does not prove
Independent references
How to interpret the TitanFlow ingredient amounts
Ingredient lists are most useful when both the ingredient and the amount are disclosed. TitanFlow’s current label does this for all five actives. Even so, comparing a label amount with a published study requires care. Extract ratios, standardization, formulation, study duration and participant characteristics can differ substantially from the product in front of you.
For example, “Pygeum africanum PE 4:1” describes an extract ratio, while “lycopene 5%” describes a standardized preparation. A milligram number alone therefore does not tell the entire story. It is also important not to add the effects of five separate ingredient studies together and assume that is the expected effect of the finished formula.
Formula transparency vs proof of effectiveness
The label gives us a strong basis for discussing what TitanFlow contains. It does not, by itself, establish clinical effectiveness. Our evidence summaries therefore use wording such as “has been studied,” “was associated with” or “showed short-term improvement in a particular trial” when the source supports it. We avoid upgrading those findings into a claim that TitanFlow treats a medical condition.
Readers who want the exact panel can view the TitanFlow Supplement Facts page; readers interested in the research context can follow the independent references listed below and in our research library.
Frequently asked questions
How many active ingredients are listed?
Five active ingredients are listed on the current label.
Does ingredient research prove TitanFlow works?
No. Research on individual ingredients does not prove the finished product has the same clinical effects.